Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXK
2101
Endeavour Silver
EXK
$3.23B
| $1.38M | ﹤0.01% |
693,946
+145,743
| +27% | +$300K |
|
|
ABB
2102
DELISTED
ABB Ltd
ABB
| $1.38M | ﹤0.01% |
66,032
-184,220
| -74% | -$4.04M |
|
2103
Texas Roadhouse
TXRH
$13.4B
| $1.38M | ﹤0.01% |
36,735
+17,367
| +90% | +$620K |
|
|
WPG
2104
DELISTED
Washington Prime Group Inc.
WPG
| $1.37M | ﹤0.01% |
11,277
-44,425
| -80% | -$5.86M |
|
2105
WEX
WEX
$6.77B
| $1.37M | ﹤0.01% |
+12,014
| New | +$1.36M |
|
2106
Globus Medical
GMED
$11.2B
| $1.37M | ﹤0.01% |
53,203
-386,102
| -88% | -$9.78M |
|
2107
Archer Daniels Midland
ADM
$38.6B
| $1.36M | ﹤0.01% |
28,277
-30,303
| -52% | -$1.53M |
|
|
CVT
2108
DELISTED
CVENT, INC.
CVT
| $1.36M | ﹤0.01% |
52,873
+38,299
| +263% | +$1.04M |
|
|
ATRS
2109
DELISTED
Antares Pharma, Inc.
ATRS
| $1.36M | ﹤0.01% |
654,546
+249,664
| +62% | +$605K |
|
2110
Vitamin Cottage Natural Grocers
NGVC
$642M
| $1.36M | ﹤0.01% |
55,079
+41,239
| +298% | +$1.06M |
|
2111
Expro Ltd
XPRO
$1.97B
| $1.36M | ﹤0.01% |
11,996
-122,542
| -91% | -$14.6M |
|
|
ALIM
2112
DELISTED
Alimera Sciences
ALIM
| $1.36M | ﹤0.01% |
19,606
-7,469
| -28% | -$515K |
|
2113
TTEC Holdings
TTEC
$68M
| $1.35M | ﹤0.01% |
49,989
-67,978
| -58% | -$1.77M |
|
2114
TriCo Bancshares
TCBK
$1.73B
| $1.35M | ﹤0.01% |
56,263
+22,484
| +67% | +$540K |
|
|
MHG
2115
DELISTED
Marine Harvest ASA
MHG
| $1.35M | ﹤0.01% |
118,410
+91,706
| +343% | +$1.09M |
|
2116
Cincinnati Financial
CINF
$26.5B
| $1.35M | ﹤0.01% |
+26,888
| New | +$1.39M |
|
2117
VanEck Gold Miners ETF
GDX
$31.9B
| $1.35M | ﹤0.01% |
+75,961
| New | +$1.48M |
|
2118
National CineMedia
NCMI
$248M
| $1.35M | ﹤0.01% |
8,449
-22,433
| -73% | -$3.56M |
|
|
BNCN
2119
DELISTED
BNC Bancorp
BNCN
| $1.34M | ﹤0.01% |
69,174
+41,599
| +151% | +$774K |
|
2120
Argan
AGX
$6.38B
| $1.34M | ﹤0.01% |
33,127
+5,551
| +20% | +$199K |
|
|
JUNO
2121
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.33M | ﹤0.01% |
+25,010
| New | +$1.33M |
|
|
EPAY
2122
DELISTED
Bottomline Technologies Inc
EPAY
| $1.33M | ﹤0.01% |
47,950
+17,191
| +56% | +$474K |
|
|
IQNT
2123
DELISTED
Inteliquent, Inc.
IQNT
| $1.33M | ﹤0.01% |
72,281
+6,076
| +9% | +$109K |
|
|
SRDX
2124
DELISTED
Surmodics
SRDX
| $1.33M | ﹤0.01% |
56,628
-9,873
| -15% | -$248K |
|
|
NP
2125
DELISTED
Neenah, Inc. Common Stock
NP
| $1.33M | ﹤0.01% |
+22,484
| New | +$1.37M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.